期刊文献+

甲氧基肾上腺素类物质、3-甲氧酪胺及嗜铬粒蛋白A在PPGL诊断中的作用 被引量:3

Role of metanephrines,3-methoxytyramine and chromogranin A in the diagnosis of PPGL
原文传递
导出
摘要 嗜铬细胞瘤和副神经节瘤(pheochromocytoma and paraganglioma,PPCL)是继发性高血压的病因之一,近年来其患病率呈上升趋势。甲氧基肾上腺素类物质(metanephrines,MNs)是儿茶酚胺(catecholamine,CA)的中间代谢产物。目前,血,尿MNs均已被广泛推荐为PPGL诊断的首选生化标志物。此外,3-甲氧酪胺(3-methoxytyramine,3-MT)和嗜铬粒蛋白A(chromogranin A,CgA)也可对PPGL的诊断和鉴别良,恶性提供一定的帮助。了解不同生化检测指标在PPCL诊断中的特点.标本采集的注意事项及方法学选择,将有助于提高临床合理规范应用。 Pheochromocytoma and paraganglioma(PPGL)results in secondary hypertension.In recent years,the prevalence of PPGL has shown an upward trend.Metanephrines(MNs)are intermediate metabolites of catecholamine(CA).Currently,plasma and urine MNs have been widely recommended as the initial biochemical markers for the diagnosis of PPGL.In addition,3-methoxytyramine(3-MT)and chromogranin A(CgA)are also useful for the diagnosis and differentiation between benign and malignant PPGL.The understanding of diagnostic advantages of different biochemical markers,precautions for specimen collection and methodological choices will help the doctors applying those tests reasonably.
作者 刘鹭 高莹 张俊清 郭晓蕙 Liu Lu;Gao Ying;Zhang Junqing;Guo Xiaohui(Department of Endocrinology,Peking University First Hospital,Beijing 100034,China)
出处 《国际内分泌代谢杂志》 2021年第2期96-99,共4页 International Journal of Endocrinology and Metabolism
基金 北京大学第一医院科研种子基金(2018SF066)。
关键词 嗜铬细胞瘤 副神经节瘤 甲氧基肾上腺素类物质 3-甲氧酪胺 嗜铬粒蛋白A Pheochromocytoma Paraganglioma Metanephrines 3-methoxytyramine Chromogranin A
  • 相关文献

参考文献2

二级参考文献45

  • 1姜蕾,王卫庆,张军妮,戴蒙,苏颋为,宁光.高效液相色谱电化学法测定血间甲肾上腺素类物质方法的建立及临床应用[J].中华内分泌代谢杂志,2004,20(6):561-563. 被引量:23
  • 2祝宇,王卫庆,沈永倩,吴瑜璇,张翀宇,芮文斌,周文龙,孙福康,刘定益,邵远,沈周俊,毕宇芳,苏颋为,姜蕾,宁光.嗜铬细胞瘤术前的高血压控制与术中高容量血液稀释[J].临床泌尿外科杂志,2006,21(8):571-573. 被引量:3
  • 3曾正陪.肾上腺髓质疾病[A].史轶蘩主编.协和内分泌和代谢学:第1版[C].北京:科学出版社,1999.1222-1244.
  • 4De Lellis RA,Lloyd RV,Heitz PU,et al.World Health Organization Classification Classification of Tumours:Pathology and Genetics of Tumours of Endocrine Organs[M].Lyon,France:IARC Press,2004:147-166.
  • 5Mazzaglia PJ.Hereditary pheochromocytoma and paraganglioma[J].J Surg Oncol,2012,106(10):580-585.
  • 6Lenders JW,Eisenhofer G,Mannelli M,et al.Phaeochromocytoma[J].Lancet,2005,366(9486):665-675.
  • 7Mannelli M,Lenders JW,Pacak K,et al.Subclinical phaeochromocytoma[J].Best Pract Res Clin Endocrinol Metab,2012,26(4):507-515.
  • 8Lenders JW,Pacak K,Walther MM,et al.Biochemical diagnosis of pheochromocytoma:which test is best?[J].JAMA,2002,287(11):1427-1434.
  • 9Eisenhofer G,Lenders JW,Goldstein DS,et al.Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines[J].Clin Chem,2005,51(4):735-744.
  • 10Eisenhofer G,Goldstein DS,Sullivan P,et al.Biochemical and clinical manifestations of dopamine-producing paragangliomas:utility of plasma methoxytyramine[J].J Clin Endocrinol Metab,2005,90(4):2068-2075.

共引文献120

同被引文献28

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部